Here Are the Biggest Obstacles Ahead for Pfizer and Moderna

Pfizer (NYSE: PFE) recently won Emergency Use Authorization (EUA) for its coronavirus vaccine. And this week, the U.S. Food and Drug Administration (FDA) will consider an EUA for Moderna (NASDAQ: MRNA). But that doesn't mean smooth sailing ahead. In this Motley Fool Live video recorded on Dec. 11, 2020, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com contributor Adria Cimino discuss potential roadblocks for Pfizer and Moderna in the coming months.

Continue reading

Source Fool.com